(a) OAC 340:100-5-26.1 applies to service recipients receiving:
(b) A psychotropic medication is a drug used to treat a mental disorder, or any drug prescribed to stabilize or improve mood, mental status, or behavior.
(c) Medication is not used as punishment, for the convenience of staff, as a substitute for a program, or in quantities that interfere with a service recipient's participation in programming.
(d) The service recipient's Personal Support Team (Team) obtains from the prescribing physician a description of data to be collected to evaluate the effectiveness of the psychotropic medication.
(e) Developmental Disabilities Services Division (DDSD) defines the use of p.r.n. medication for behavioral control to be a highly restrictive procedure per OAC 340:100-3-34. In cases where a medication is ordered to be administered p.r.n. for behavioral control, the service recipient's Team ensures there is a written protocol for the administration of the p.r.n. medication from the prescribing physician as part of the protective intervention planning per OAC 340:100-5-57, and contract provider agency staff will follow critical incident reporting requirements per OAC 340:100-3-34.
(f) Psychotropic medication is monitored in accordance with OAC 340:100-5-26.
(g) Monitoring for side effects such as tardive dyskinesia is in accordance with OAC 340:100-5-29.
(h) The Team implements positive support strategies according to OAC 340:100-5-57.
(i) The Team reviews the use of psychotropic medication annually via Form 06HM067E, Annual Psychotropic Medication Review
(j) When psychotropic medication is used to treat the symptoms of a psychiatric diagnosis and the medication is determined ineffective in eliminating or substantially reducing symptoms, the Team provides pertinent information about the service recipient's status to the prescribing physician.
(k) If psychotropic medication is ordered p.r.n., the Team meets with appropriate service providers to review considerations per OAC 340:100-5-26.1(i) as soon as possible, but within five working days.
(l) Psychotropic medication is considered to be in use only for behavioral control if prescribed without a confirmed psychiatric diagnosis appropriate for the medication.
-
(1) When the service recipient and service recipient's Team determine the medication is effective in eliminating or substantially reducing targeted behaviors, the Team submits documentation to the appropriate committees for review as described in (A) through (C).
-
-
(B) The Team must submit the plan to the Human Rights Committee (HRC) and Statewide Behavior Review Committee (SBRC) annually.
-
(C) The Team documents the service recipient's targeted behavior in conjunction with physician-guided efforts to reach the optimal effective dosage.
-
(2) When the service recipient and service recipient's Team determine the medication is ineffective in eliminating or substantially reducing targeted behaviors, documentation and review are required as described in (A) through (D).
-
(A) The Team meets and reviews available documentation at least quarterly while the medication is in place and continues to be ineffective.
-
(B) The Team provides pertinent information about the service recipient's status to the prescribing physician.
-
(C) Documentation of the information provided and physician's response is submitted to the positive support field specialist for review by SBRC.
-
(D) The Team must annually submit a protective intervention plan that includes a physician-approved psychotropic medication reduction or adjustment plan to HRC for review and SBRC for approval.